Menopause symptoms can significantly affect sleep, temperature regulation, vaginal health, mood and quality of life. Peptides are increasingly marketed as menopause treatments, but most experimental peptides do not have the same evidence base as established menopausal therapies.
What Treatments Have the Strongest Evidence?
For appropriate patients, menopausal hormone therapy is among the most effective treatments for hot flashes and night sweats. Local vaginal estrogen can be useful for genitourinary symptoms. Nonhormonal options are also available when hormone therapy is not appropriate or preferred.
Where Do Peptides Fit?
Some peptide-based medications have legitimate approved uses, but experimental peptides promoted for anti-aging, sleep, body composition or “hormone balance” generally have limited evidence for menopause symptom treatment.
Why Claims Need Careful Review
Marketing often groups many different compounds together under “peptide therapy.” Each peptide has a different mechanism, evidence base, regulatory status and safety profile. A laboratory or animal finding is not proof of clinical benefit for menopausal symptoms.
Safety and Compounding
FDA has identified safety concerns with several compounded peptides. Concerns can include immunogenicity, peptide-related impurities and limited human safety data.
A Better Starting Point
Evaluation should focus on the actual symptom pattern, menstrual history, uterus status, medical risks and whether established menopausal hormone therapy or nonhormonal treatment is appropriate.
Learn more about menopause therapy, perimenopause treatment and our peptide therapy approach.
